News 10 mai 2024 BioVersys extends Series C financing round to 44.9 million Swiss francs BioVersys is bolstering its partnership with GSK in order to accelerate the development of alpibectir for the treatment of tuberculosis. GSK is s...
Business travel in the target market Individualized and group business trips on specific topics or industries to expand your network in the target market.
News 13 dez 2023 Macrogen establishes foothold in Basel Macrogen Europe is set to move into the Novartis Campus of Switzerland Innovation Park Basel Area. As with its parent company, the South Korean b...
SWISS Pavilion SWISS BIOTECH Pavilion @ BIO-Asia Taiwan 2024 24 jul 2024–28 jul 2024 Nangang District Taiwan
News 30 jan 2024 Top Stories from Western Switzerland (January 2024) From groundbreaking advancements in agrifood and robotics to strategic economic reforms and pioneering research in space and medicine, discover W...
Member of the Month 03 fev 2023 BROMATECH Suisse SA: "S-GE helps us better understand sales markets as well as the distribution channels" BROMATECH Switzerland is active in the development of dietary supplements based on lactic acid bacteria capable of interacting in a targeted and ...
News 26 jan 2022 Basel Area – exactly the right chemistry for South Korean pharma companies KPBMA and Basel Area Business & Innovation establish tailored collaboration to support Korean biopharmaceutical companies to enter the Europe...
News 19 out 2023 Mimix Biotherapeutics’ breakthrough tissue regeneration treatment receives strategic investment Biel-based Mimix Biotherapeutics announced the closure of a significant investment round, drawing participation from both European and Asian inve...
News 18 out 2023 Siegfried and Lonza secure top positions in global pharmaceutical outsourcing rankings Valais-based pharmaceutical companies Lonza and Siegfried have been recognized among the leading players in the global outsourcing landscape, wit...
News 01 out 2020 Monarch Bioimplants secures record investment Monarch Bioimplants will receive a total of €20 million over the next 36 months from New York investment group GEM. This is the highest amount ev...
Global Opportunities 29 out 2018 Healthcare Tech in Mauritius: A booming market for Swiss companies Mauritius has become one of the fastest advancing destinations in the fields of Medical Technology and Treatment in Africa. While the official ma...
Export from Switzerland Global Opportunities Short-term market opportunities for Swiss SMEs: Use our new service and benefit from exciting export opportunities in selected industries and mar...
Global Network Offices around the world In collaboration with the Federal Department of Foreign Affairs (FDFA), we presently maintain offices in more than 25 countries.
News 06 out 2022 Biopôle expands further with the construction of three new buildings Biopôle has announced that Edmond de Rothschild Real Estate SICAV will be investing in the construction of three new buildings on the campus in E...